Drug Approval | May 07, 2026
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Approval strengthens the company’s growing international anti-infective portfolio
Approval strengthens the company’s growing international anti-infective portfolio
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
This is an exciting and meaningful milestone for GRIN Therapeutics
The standout story remains Wegovy, particularly its new oral formulation
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Subscribe To Our Newsletter & Stay Updated
